Can I request a statement from the Cabinet Secretary for health on the work programme of the All Wales Medicines Strategy Group? While I very much welcome the introduction of the new treatment fund, and the review of the individual patient funding requests system in Wales, which, in my view, is long overdue, I am concerned that access to new drugs will continue to be constrained by the timescales set out by the AWMSG. I’m currently trying to help a constituent access Avastin, for cervical cancer. It is available on the NHS in England, and in Scotland, for advanced cervical cancer, which is putting my constituents at a disadvantage, because the AWMSG are only just beginning to evaluate it here.